Embed this press release by copying the code below:
NASDAQ: HRTX Long Term Shareholder Notice: Investigation of Potential Wrongdoing at Heron Therapeutics, Inc.
NASDAQ: HRTX Long Term Shareholder Notice: Investigation of Potential Wrongdoing at Heron Therapeutics, Inc.